In the tumor microenvironment, TGF-β drives the conversion of Eomes+CD49a−CD49b+ NK cells favoring tumor immunosurveillance to EomesintCD49a+CD49b− ILC1s that are unable to control tumor growth, a mechanism by which tumors evade the innate immune system (58). This evidence concerns the gene TGFB1 and neoplasm.